Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05158127 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Skin Ulcer

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Suspended to Not Yet Recruiting
    • Primary and study completion dates: Jan 2026 to Dec 2028
    • Start date: Dec 2022 to Dec 2025
    • Site contact updated
    v4
  2. Trial status: Recruiting to Suspended Sponsor's reason: Updating Protocol
    • Start date: Jan 2022 to Dec 2022
    • Site details revised
    v3
  3. Site contact updatedv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This trial will study the safety and efficacy of intravenous infusion and intralesional injection of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Skin Ulcer
Trial Details
NCT Number NCT05158127
Lead Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Conditions
(from sponsor)		 Skin Ulcer
Related terms Skin Ulcer
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov